Jessica Ezzell Hunter

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

A systematic framework for selecting gene-condition pairs for inclusion in newborn sequencing panels: Early check implementation

Identifying factors and causal chains associated with optimal implementation of Lynch syndrome tumor screening: An application of coincidence analysis

Intrasubject variability of sustained attention is associated with elevated self-reported attention deficits in women with a fragile X premutation allele

Implementing evidence-based assertions of clinical actionability in the context of secondary findings: Updates from the ClinGen Actionability Working Group

Genetic testing uptake among ovarian cancer survivors in the Genetic Risk Analysis in Ovarian Cancer (GRACE) study

Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population

Improving care for marginalized populations at risk for hereditary cancer syndromes: Innovations that expanded reach in the CHARM Study

"Go ahead and screen" - advice to healthcare systems for routine lynch syndrome screening from interviews with newly diagnosed colorectal cancer patients

Most people share genetic test results with relatives even if the findings are normal: Family communication in a diverse population

Insight and recommendations for fragile x-premutation-associated conditions from the fifth international conference on FMR1 premutation

A picture is worth a thousand words: Advancing the use of visualization tools in implementation science through process mapping and matrix heat mapping

An examination of the ethical and legal limits in implementing "traceback testing" for deceased patients

An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial

Should health systems share genetic findings with at-risk relatives when the proband is deceased?: Interviews with individuals diagnosed with Lynch syndrome

Establishing the medical actionability of genomic variants

EE139 Using a user-friendly modeling tool to inform and guide local decision-making for lynch syndrome screening at healthcare systems

ClinGen's Pediatric Actionability Working Group: Clinical actionability of secondary findings from genome-scale sequencing in children and adolescents

Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population

Motivations and concerns of patients considering participation in an implementation study of a hereditary cancer risk assessment program in diverse primary care settings